• Open-Platform Digital Light Printing for 96-Well Hydrogel Ar

  2026-05-03

  This study introduces an open-platform digital light printer (OP-DLP) enabling precise, high-throughput hydrogel printing and localized light-activation in a 96-well format. The platform addresses reproducibility and customization challenges in biomaterials and cell-based research, with implications for integrin-targeted assay development and spatially controlled biological studies.

• Targeting BCL-XL and MCL-1 in Glioblastoma: Apoptotic Sensit

  2026-05-02

  This article reviews a recent study revealing that glioblastoma (GBM) exhibits increased expression of anti-apoptotic BCL-XL and MCL-1, resulting in heightened sensitivity to BH3-mimetic inhibitors. The findings support targeting these proteins as a therapeutic strategy and provide a mechanistic rationale for selective BCL-XL inhibitor development.

• Y-27632 dihydrochloride (A3008): Reliable ROCK Inhibition fo

  2026-05-02

  This article addresses persistent laboratory challenges in cell viability, proliferation, and invasion assays, demonstrating how Y-27632 dihydrochloride (SKU A3008) delivers reproducible, data-driven solutions. Integrating real-world scenarios, protocol guidance, and vendor selection insights, it helps biomedical researchers achieve robust results using APExBIO's Y-27632 dihydrochloride.

• Anlotinib Hydrochloride: Advanced Mechanisms and Translation

  2026-05-01

  Explore the advanced multi-target mechanisms of Anlotinib hydrochloride, a leading tyrosine kinase inhibitor. This article uniquely bridges preclinical insights and practical assay design, optimizing cancer research beyond standard protocols.

• Balsalazide Prodrug Innovation in Ulcerative Colitis Managem

  2026-04-30

  The referenced study provides a systematic review of balsalazide, a novel 5-aminosalicylate prodrug, highlighting its improved efficacy and rapid onset for inducing remission in mild to moderate ulcerative colitis. The findings support balsalazide's clinical relevance and underscore its mechanism of targeted colonic delivery, with implications for the future of inflammation research.

• Levofloxacin: Synthetic Fluoroquinolone Antibiotic for Preci

  2026-04-30

  Levofloxacin, a synthetic fluoroquinolone antibiotic, is redefining research on bacterial DNA replication, osteoblast growth inhibition, and cartilage metabolism. This guide breaks down applied workflows, troubleshooting strategies, and the latest resistance insights, enabling researchers to maximize assay reliability and relevance.

• DAPI Staining for Mechanistic Cell Fate Analysis in IDD Mode

  2026-04-29

  This thought-leadership article explores the mechanistic and translational value of DAPI (4',6-Diamidino-2-Phenylindole) staining in the context of intervertebral disc degeneration (IDD), specifically focusing on the interplay between senescent nucleus pulposus cells and macrophage polarization. It combines biological rationale, recent experimental breakthroughs, competitive benchmarking, and forward-looking translational insights, while positioning APExBIO’s DAPI Solution (1 mg/mL) as a pivotal tool for rigorous, high-contrast nuclear visualization and viability assessment in fixed and apoptotic cells.

• Quinolone–Coumarin Hybrids and Novobiocin: In Vitro Anti-Tox

  2026-04-29

  A recent in vitro study demonstrates that hybrids of fluoroquinolones and novobiocin, along with novobiocin itself, exhibit potent and selective anti-Toxoplasma gondii activity with reduced toxicity to host cells. These findings highlight new chemotypes for antiparasitic drug development and provide a foundation for future studies evaluating DNA-targeting aminocoumarin antibiotics in metabolic enzyme protease and apoptosis signaling pathway research.

• Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin

  2026-04-28

  Liu et al. (2025) reveal that maintenance of social memory in mice critically depends on social interaction-induced proteolytic fragments of neuroligin 1 in the ventral hippocampus. Their mechanistic findings link α- and γ-secretase cleavage, NLG1-CTD signaling, and cofilin phosphorylation to synaptic plasticity and memory persistence, advancing our understanding of molecular memory maintenance.

• Hoechst 33258: Advanced DNA Staining for Live and Fixed Cell

  2026-04-28

  Discover the nuanced advantages of Hoechst 33258, a bis-benzimide DNA stain optimized for fluorescence microscopy and cell cycle analysis. This cornerstone article explores its molecular mechanism, assay optimization, and importance in tumor cell research.

• Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa

  2026-04-27

  This study provides an in-depth analysis of how size and PEGylation influence the hepatic distribution and cellular uptake of iron oxide nanoparticles. The findings challenge prevailing assumptions about liver cell involvement in nanoparticle clearance, highlighting that hepatocytes and hepatic stellate cells may play more prominent roles than previously thought, with implications for optimizing nanomedicine design.

• Scenario-Driven Best Practices with Mifepristone (RU486) SKU

  2026-04-27

  This article delivers evidence-based guidance for integrating Mifepristone (RU486), SKU B1511, into cell viability, proliferation, and hormone receptor assays. Drawing on real laboratory scenarios and current literature, it demonstrates how APExBIO’s high-purity Mifepristone enhances reproducibility, offers robust workflow compatibility, and supports advanced cancer and reproductive biology research.

• Ibrexafungerp Activity Against Echinocandin-Resistant Candid

  2026-04-26

  This study systematically investigates the in vitro efficacy of ibrexafungerp (MK 3118) against a well-characterized collection of echinocandin-resistant Candida isolates, including detailed analysis by FKS mutation type. Findings reveal that ibrexafungerp retains notable activity, particularly in strains with specific hotspot mutations, supporting its potential as a therapeutic alternative in the context of rising echinocandin resistance.

• Broad-Spectrum Bivalent mRNA Vaccine Neutralizes SARS-CoV-2

  2026-04-25

  Lu et al. report a novel bivalent mRNA vaccine (RQ3025) that induces broad, high-titer neutralizing antibody responses against multiple SARS-CoV-2 variants in animal models. Their preclinical study demonstrates enhanced immunogenicity and safety compared to monovalent mRNA vaccines, providing a foundation for future clinical development and variant-specific vaccine strategies.

• Spider Toxin v-Agatoxin-IVA Reveals N-Type Ca Channel Blocka

  2026-04-24

  Sidach and Mintz’s study rigorously redefines the pharmacological selectivity of the spider toxin v-Agatoxin-IVA in mammalian neurons. By demonstrating both high-affinity and low-affinity blockade across P-type, N-type, and Q-type calcium channels, the work clarifies limitations in using this toxin for functional channel classification and underlines the need for more selective agents in neurophysiological research.

15884 records 1/1059 page Next 12345 下5页 Last page